Acadia Healthcare Company, Inc.
ACHC · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | -1.11 | -0.54 | -1.53 |
| FCF Yield | 6.51% | 0.41% | -2.39% | -0.47% |
| EV / EBITDA | 32.09 | 55.26 | 52.48 | 46.61 |
| Quality | ||||
| ROIC | 1.85% | 0.16% | 1.66% | 1.99% |
| Gross Margin | 96.72% | 32.60% | 96.31% | 96.37% |
| Cash Conversion Ratio | 1.91 | 3.52 | 1.27 | 3.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.50% | 5.15% | 5.37% | 6.51% |
| Free Cash Flow Growth | 1,063.23% | 113.22% | -220.15% | -260.36% |
| Safety | ||||
| Net Debt / EBITDA | 16.81 | 24.64 | 18.67 | 11.61 |
| Interest Coverage | 4.05 | 0.46 | 3.44 | 4.92 |
| Efficiency | ||||
| Inventory Turnover | 4.90 | 0.00 | 5.05 | 5.37 |
| Cash Conversion Cycle | -625.02 | 10.97 | -666.44 | -541.10 |